Postoperative bypass bleeding: a bypass-associated dilutional (BAD) coagulopathy?

Area of Science:

• Cardiovascular Science
• Hematology
• Surgical Complications

Background:

• Post-bypass bleeding is a significant complication.
• Existing literature describes various associations with post-bypass bleeding.
• The underlying mechanisms, particularly the role of dilution, require further elucidation.

Purpose of the Study:

• To investigate dilution as a primary cause of post-bypass bleeding.
• To elucidate the anomalous behavior of heparinized blood upon dilution.
• To understand the cascade of events leading to coagulopathy during cardiopulmonary bypass.

Main Methods:

• Hypothesizing dilution as a central mechanism in bypass-associated bleeding.
• Analyzing the effect of blood dilution on clotting times.
• Examining the impact of low blood volume on clotting factor concentration during cardiopulmonary bypass.

Main Results:

• Heparinized blood exhibits anomalous clotting behavior with dilution, initially shortening then rapidly lengthening clotting times.
• Low blood volume patients undergoing cardiopulmonary bypass face significant clotting factor dilution, exceeding whole blood dilution levels.
• Severe dilution can critically lower plasma clotting factors, potentially leading to excess protamine administration and marked coagulopathy.

Conclusions:

• Dilution is a critical underlying factor contributing to post-bypass bleeding.
• The interplay between diluted clotting factors and protamine can result in significant coagulopathy.
• Understanding these dilution effects is crucial for managing bleeding complications after cardiopulmonary bypass.